BR112022026615A2 - Produtos combinados em dose tripla fixa de antibióticos, regime de dosagem, métodos e kits para tratamento de infecções por micobactérias pulmonares não tuberculosas - Google Patents

Produtos combinados em dose tripla fixa de antibióticos, regime de dosagem, métodos e kits para tratamento de infecções por micobactérias pulmonares não tuberculosas

Info

Publication number
BR112022026615A2
BR112022026615A2 BR112022026615A BR112022026615A BR112022026615A2 BR 112022026615 A2 BR112022026615 A2 BR 112022026615A2 BR 112022026615 A BR112022026615 A BR 112022026615A BR 112022026615 A BR112022026615 A BR 112022026615A BR 112022026615 A2 BR112022026615 A2 BR 112022026615A2
Authority
BR
Brazil
Prior art keywords
fixed dose
mac
treatment
fixed
tuberculous
Prior art date
Application number
BR112022026615A
Other languages
English (en)
Portuguese (pt)
Inventor
Fathi Reza
Raday Gilead
Anderson Patricia
Offman Elliot
Original Assignee
Redhill Biopharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Redhill Biopharma Ltd filed Critical Redhill Biopharma Ltd
Publication of BR112022026615A2 publication Critical patent/BR112022026615A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112022026615A 2020-06-30 2021-06-30 Produtos combinados em dose tripla fixa de antibióticos, regime de dosagem, métodos e kits para tratamento de infecções por micobactérias pulmonares não tuberculosas BR112022026615A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063046335P 2020-06-30 2020-06-30
US202063046322P 2020-06-30 2020-06-30
PCT/IB2021/000451 WO2022003421A2 (en) 2020-06-30 2021-06-30 Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections

Publications (1)

Publication Number Publication Date
BR112022026615A2 true BR112022026615A2 (pt) 2023-01-24

Family

ID=79032054

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022026615A BR112022026615A2 (pt) 2020-06-30 2021-06-30 Produtos combinados em dose tripla fixa de antibióticos, regime de dosagem, métodos e kits para tratamento de infecções por micobactérias pulmonares não tuberculosas

Country Status (11)

Country Link
US (1) US11590154B2 (cg-RX-API-DMAC7.html)
EP (1) EP4171546A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023533472A (cg-RX-API-DMAC7.html)
KR (1) KR20230028502A (cg-RX-API-DMAC7.html)
CN (1) CN115768420A (cg-RX-API-DMAC7.html)
AU (1) AU2021298936A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022026615A2 (cg-RX-API-DMAC7.html)
CA (1) CA3187031A1 (cg-RX-API-DMAC7.html)
IL (1) IL299287A (cg-RX-API-DMAC7.html)
MX (1) MX2023000165A (cg-RX-API-DMAC7.html)
WO (1) WO2022003421A2 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025026423A1 (en) * 2023-08-02 2025-02-06 Shenzhen Pharmacin Co., Ltd. Compositions, their use and manufacture for treatment of gastrointestinal conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2285923C (en) 1997-04-01 2013-03-12 Thomas Julius Borody Methods and compositions for treating inflammatory bowel disease
PL2247291T3 (pl) * 2008-02-08 2019-05-31 Red Hill Biopharma Ltd Sposoby i kompozycje do leczenia nieswoistego zapalenia jelit
TWI573590B (zh) * 2011-09-20 2017-03-11 雷希爾生藥有限公司 治療自體免疫疾病之組成物及方法
CA3000709A1 (en) * 2015-10-01 2017-04-06 Memorial Sloan-Kettering Cancer Center Inhibitors of menaquinone biosynthesis
WO2017194734A1 (en) * 2016-05-13 2017-11-16 Technische Universität München Means and methods for treating mycobacterial diseases

Also Published As

Publication number Publication date
WO2022003421A3 (en) 2022-03-17
IL299287A (en) 2023-02-01
CN115768420A (zh) 2023-03-07
KR20230028502A (ko) 2023-02-28
JP2023533472A (ja) 2023-08-03
MX2023000165A (es) 2023-02-22
CA3187031A1 (en) 2022-01-06
AU2021298936A1 (en) 2023-01-19
US20210401865A1 (en) 2021-12-30
US11590154B2 (en) 2023-02-28
EP4171546A4 (en) 2024-03-13
WO2022003421A2 (en) 2022-01-06
EP4171546A2 (en) 2023-05-03

Similar Documents

Publication Publication Date Title
McCARTHY Pyostomatitis vegetans: report of three cases
Elborn et al. Safety and efficacy of prolonged levofloxacin inhalation solution (APT-1026) treatment for cystic fibrosis and chronic Pseudomonas aeruginosa airway infection
OA12845A (en) Single dose azithromycin for treating respiratory infections.
Weiss et al. Acute nonspecific lung abscess: a controlled study comparing orally and parenterally administered penicillin G
Yuan et al. Randomized controlled clinical trial on the efficacy of fosfomycin trometamol for uncomplicated gonococcal urethritis in men
HUP0002125A2 (hu) Tökéletesített retard hatású mikróbaellenes szerek
Miller et al. Successful treatment of actinomycosis with stilbamidine
AU777508B2 (en) Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate
Brodie et al. Comparative study of cefuroxime axetil and amoxycillin in the treatment of acute sinusitis in general practice
MX2023000165A (es) Productos de combinacion de dosis fijas de tres antibioticos, regimen de dosificacion, metodos y kits para tratar infecciones micobacterianas pulmonares no tuberculosas.
BR0107881A (pt) Uso de fsh tratamento de infertilidade
Schwartz et al. The Management of Massive Tuberculous Pneumonia, A Therapeutic Review of Seventy-Five Cases
Eastlake Jr et al. Use of para-aminosalicylic acid in chronic pulmonary tuberculosis
HUP0201629A2 (hu) Eletriptánt és ciklodextrinszármazékot tartalmazó gyógyászati komplex, ezt tartalmazó gyógyszerkészítmény, eljárás az előállítására és alkalmazása
FINLAND et al. Antibiotic Susceptibility and Phage Types of Pathogenic Staphylococci: A Study of Two Hundred Ten Strains Isolated at Boston City Hospital in 1955
Blanshard Sputum viscosity and postoperative pulmonary atelectasis
Becker et al. Evaluation of antibiotics in the control of pustular acne vulgaris
Goldstein et al. Erythromycin for anaerobic pleuropulmonary and soft-tissue infections
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
Pang et al. Efficacy and safety of bismuth quadruple therapy containing minocycline and berberine for initial eradication of Helicobacter pylori: A noninferiority, randomized controlled trial
LEVINE Inhalation therapy in chronic bronchial infections
PT100284B (pt) Anti-helmintico de benzimidazol para uso no fabrico de um medicamento para o tratamento de infeccao microsporideos
RU2189234C2 (ru) Способ лечения туберкулеза органов дыхания с выраженной экссудативной реакцией у детей
Whitby et al. Comparison of fleroxacin and amoxicillin in the treatment of uncomplicated urinary tract infections in women
DUNNER et al. Streptomycin para-aminosalicylate in the treatment of pulmonary tuberculosis